Out of funds, could this be the end of California's Stem Cell Agency?


Grim news out of the California Institute for Regenerative Medicine (CIRM) as it announced that it has approved funding for the last of the projects involving the use of stem cells to develop cure for various diseases and disorders as it has allocated the last of its $3 billion in funding voters approved in 2004 as a result of the landmark Prop. 71.

CIRM has so far funded 55 clinical trials though spinal cord injury research has only received a small fraction of the available funds at $55 million allocated. The agency is staking its existence on a proposed ballot to take to the voters in 2020 with the lofty goal of raising $5.5 billion.

The agency has weathered many controversies over the years regarding its spending practices and results of its investments in the research work. You can read more about what’s at stake HERE.